Estimaciones de analistas de Wall Street para Myomo, Inc. (MYO): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 7 |
| Mantener | 1 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 8 |
| Calificación media (1-5) | 0.88 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-09 | $-0.08 | ||
| 2026-08-05 | $-0.07 | $-0.10 | +28.6% |
| 2026-05-07 | $-0.09 | $-0.12 | +25.0% |
| 2026-03-09 | $-0.08 | $-0.09 | +11.1% |
| 2025-11-10 | $-0.09 | $-0.11 | +18.2% |
| 2025-08-11 | $-0.11 | $-0.11 | +0.0% |
| 2025-05-07 | $-0.08 | $-0.08 | +0.0% |
| 2025-03-10 | $-0.01 | $-0.02 | +50.0% |
Ratios de valoración
| Precio / Valor contable | 9.45 |
| EV / EBITDA | -5.66 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.1M | $1.6M | $2.4M | $3.8M | $7.6M | $13.9M | $15.6M | $19.2M | $32.6M | $40.9M |
| Coste de Ventas | $282164 | $505280 | $728279 | $917623 | $2.6M | $3.5M | $5.3M | $6.1M | $9.4M | $14.0M |
| Beneficio Bruto | $821113 | $1.1M | $1.7M | $2.9M | $5.0M | $10.3M | $10.3M | $13.2M | $23.2M | $26.9M |
| I+D | $1.1M | $1.8M | $1.8M | $2.2M | $1.7M | $2.6M | $2.5M | $2.6M | $4.8M | $6.9M |
| Generales y Administrativos | $3.0M | $5.8M | $10.4M | $11.6M | $13.8M | $18.0M | $18.4M | $18.8M | $24.6M | $34.3M |
| Gastos Operativos | $4.1M | $7.6M | $12.2M | $13.7M | $15.5M | $20.6M | $20.9M | $21.4M | $29.4M | $41.3M |
| Beneficio Operativo | -$3.3M | -$6.5M | -$10.5M | -$10.8M | -$10.5M | -$10.3M | -$10.7M | -$8.2M | -$6.2M | -$14.4M |
| EBITDA | -$3.3M | -$6.5M | -$10.5M | -$10.7M | -$11.0M | -$9.9M | -$10.1M | -$7.5M | -$5.0M | -$12.4M |
| Gastos por Intereses | $342020 | $358916 | $358916 | $113631 | $474709 | 0 | 0 | 0 | 0 | $927800 |
| Beneficio Antes de Impuestos | -$3.6M | -$12.1M | -$10.3M | -$10.7M | -$11.6M | -$10.3M | -$10.7M | -$8.0M | -$5.8M | -$15.1M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | $88928 | $69937 | $156002 | $365617 | $504532 |
| Beneficio Neto | -$3.6M | -$12.1M | -$10.3M | -$10.7M | -$11.6M | -$10.4M | -$10.7M | -$8.1M | -$6.2M | -$15.6M |
| BPA | $-0.56 | $-84.05 | $-25.18 | $-19.20 | $-3.62 | $-1.78 | $-1.52 | $-0.28 | $-0.16 | $-0.37 |
| BPA Diluido | $-0.56 | $-84.05 | $-25.15 | $-19.20 | $-3.62 | $-1.78 | $-1.52 | $-0.28 | $-0.16 | $-0.37 |
| Acciones en Circulación (Diluidas) | $6.4M | $143927 | $410152 | $553787 | $3.3M | $5.8M | $7.1M | $29.5M | $37.8M | $41.9M |
Precio
| Precio | $1.29 |
| Capitalización | $50M |
| Bolsa | AMEX |
| País | US |
Empresas relacionadas: ECOR · HYPD · IGC · MIRA · MLSS · MODD · NMTC
Explorar sector: Healthcare · Medical - Devices
Más secciones de MYO: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones